Endometrial (Uterine) Cancer: Symptoms, Causes, and More

If the uterus had a suggestion box, it would probably include: “Please stop surprising me.” Endometrial (uterine) cancer often announces itself in a very un-subtle waymost commonly with abnormal bleeding. That can feel scary, annoying, or both (the uterus is talented), but the upside is that noticeable symptoms can lead to earlier evaluation and treatment.

Let’s break down what endometrial cancer is, what symptoms to watch for, what actually causes the risk to rise, and what diagnosis and treatment typically look likewithout turning this into a doom-scroll. (Information helps. Panic doesn’t.)

What is endometrial (uterine) cancer?

Endometrial cancer starts in the endometrium, the inner lining of the uterus. It’s the most common type of “uterine cancer.” The word uterine is the umbrella; endometrial is the most common rain under it.

There are other rarer cancers that can start in the uterus (like uterine sarcomas), but when most people say “uterine cancer,” they usually mean endometrial cancer.

Symptoms: the uterus waving a tiny red flag (sometimes literally)

The most common symptom is abnormal vaginal bleeding. The key word is “abnormal” for youtiming, amount, and pattern matter.

Common symptoms

• Bleeding after menopause (even light spotting)
• Bleeding between periods or periods that suddenly become unusually heavy or unpredictable
• Unusual vaginal discharge (watery, blood-tinged, or different than your baseline)
• Pelvic pain or pressure
• Pain during sex
• Painful or difficult urination (less common, but possible)

Menopause and bleeding: a rule of thumb

Once your periods have stopped, bleeding is not considered normal. That doesn’t automatically mean cancermany non-cancer causes existbut it does mean it’s worth prompt medical evaluation.

When to call a clinician sooner rather than later

If you notice postmenopausal bleeding, persistent spotting, or new pelvic pain/pressure that doesn’t quit, it’s reasonable to contact a healthcare professional. Endometrial cancer has no routine screening test for people without symptoms, so paying attention to symptoms matters.

Causes and risk factors: why risk goes up

Endometrial cancer doesn’t usually have one single “cause.” Instead, it’s linked to a mix of hormonal exposure, genetics, age, and health factors. If you want a simple mental model: estrogen encourages endometrial growth, while progesterone helps keep that growth in check. When the body experiences long stretches of higher estrogen with not enough progesterone (“unopposed estrogen”), risk tends to rise.

Major risk factors (the big ones clinicians think about)

• Age: Risk increases as people get older, especially after menopause.
• Obesity: Fat tissue can increase estrogen levels, particularly after menopause, which can stimulate the endometrium.
• Estrogen-only hormone therapy: Taking estrogen without progesterone after menopause can raise risk for people who still have a uterus.
• Irregular ovulation (including PCOS): If ovulation is infrequent, progesterone exposure may be lower over time.
• Diabetes and some metabolic health patterns: Often linked with higher risk, partly overlapping with weight and hormone pathways.
• Tamoxifen: A medication used in some breast cancer settings that can act like estrogen in the uterus.
• Family history and inherited syndromes: Especially Lynch syndrome, which significantly increases risk.
• Reproductive history: Never being pregnant, starting periods early, or going through menopause later can increase lifetime estrogen exposure.
• Endometrial hyperplasia (a thickening of the lining): Some types can raise risk, especially if atypical cells are present.
• Past pelvic radiation: Can increase risk for certain uterine cancers.

“But I don’t have risk factors…”

Totally possible. Some people develop endometrial cancer without obvious risk factors, and many people with multiple risk factors never develop it. Risk factors are like weather forecasts: they shift probability, not destiny.

Genetics and tumor testing (why biomarkers matter now)

Modern care often includes testing the tumor for certain biomarkersespecially mismatch repair deficiency / microsatellite instability (often discussed in connection with Lynch syndrome)because results can influence next steps, family risk evaluation, and sometimes treatment options for advanced or recurrent disease.

Diagnosis: how doctors figure it out

Because there’s no standard screening test for most people without symptoms, diagnosis usually starts when someone reports abnormal bleeding or related symptoms.

Step 1: History + exam

A clinician will ask about bleeding patterns, medications (including tamoxifen or hormone therapy), menopause status, pregnancy history, and family cancer history. A pelvic exam may be performed to check for other causes of bleeding.

Step 2: Imaging (often) transvaginal ultrasound

A transvaginal ultrasound can measure endometrial thickness and look for structural causes (like fibroids or polyps). In postmenopausal bleeding, ultrasound may be used as an initial evaluation step. It is not meant as a screening tool for people without symptoms.

Step 3: Tissue diagnosis (the decisive part)

The diagnosis of endometrial cancer is typically confirmed with an endometrial biopsy, where a small sample of the uterine lining is collected and examined under a microscope. If the sample is insufficient or results are unclear, additional procedures may be recommended, such as:

• Hysteroscopy (looking inside the uterus with a thin camera)
• Dilation and curettage (D&C) to collect more tissue

Important myth-buster: a Pap test is not a uterine cancer screening test

A Pap test is designed to screen for cervical cancer, not endometrial cancer. Occasionally it may hint that something is off, but it is not the standard screening tool for endometrial cancer. If you have symptoms, the evaluation is different (often biopsy-based).

Staging and grading: “How far?” and “How aggressive?”

After diagnosis, your care team may describe the cancer by:

• Stage: how far it has spread (from confined to the uterus to involving nearby tissues or more distant sites)
• Grade: how abnormal the cells look under a microscope (often linked with how fast the cancer may grow)
• Histologic type: the subtype of cancer cells
• Molecular features: biomarkers that help refine risk and guide treatment decisions

These details help tailor treatmentbecause “uterine cancer” is not one-size-fits-all.

Treatment: what it often looks like

Treatment depends on stage, subtype, grade, biomarkers, overall health, and personal goals. Many cases are treated successfully, often beginning with surgery.

Surgery (often the main event)

The most common treatment is a hysterectomy (removal of the uterus). Surgery may also include removing the ovaries and fallopian tubes and evaluating lymph nodes, depending on individual risk features.

Radiation therapy

Radiation may be used after surgery in some cases to reduce recurrence risk, or as part of treatment when surgery isn’t the best option. It can be delivered externally, internally (brachytherapy), or both.

Chemotherapy

Chemotherapy may be recommended for higher-risk disease, more advanced stages, or certain aggressive subtypes. It’s sometimes used after surgery or in recurrent disease.

Hormone therapy

Because many endometrial cancers are influenced by hormones, hormone therapy can be an option in specific scenariosparticularly for certain tumor types or when fertility preservation is a goal and the situation is appropriate for conservative management (a decision that requires specialist care and close monitoring).

Targeted therapy and immunotherapy (for selected cases)

For advanced or recurrent endometrial cancer, newer therapies may be considered, especially when tumor biomarker testing suggests they’re likely to help (for example, mismatch repair deficiency / MSI-high status is one important category). Treatment here is highly individualized and guided by oncology specialists.

Risk reduction: what you can influence (without blaming yourself)

Let’s be crystal clear: nobody “earns” cancer. Still, some steps may reduce risk or improve overall health:

• Address metabolic health where possible: weight management, physical activity, diabetes care
• Review hormone therapy choices with a clinician (especially estrogen-only therapy if you have a uterus)
• Know your family history and ask about genetic counseling if multiple relatives have uterine/colon/ovarian cancers
• Be alert to abnormal bleeding and get it evaluated

A note on birth control and endometrial cancer risk

Some hormonal contraceptivesparticularly combined oral contraceptives (estrogen + progestin)have been associated with a lower risk of endometrial cancer, and the protective effect can last years after stopping. This doesn’t mean everyone should take them, but it is a useful “file away” fact for informed discussions with a healthcare professional.

Frequently asked questions

Is endometrial cancer the same as cervical cancer?

No. Cervical cancer starts in the cervix; endometrial cancer starts in the uterine lining. They’re different diseases with different screening and evaluation pathways.

Can you get endometrial cancer before menopause?

Yes. It’s more common after menopause, but it can occur earlierespecially in the presence of risk factors like chronic irregular ovulation (including PCOS), obesity, or genetic predisposition.

Does postmenopausal bleeding always mean cancer?

Nobut it should be evaluated promptly. Many benign conditions can cause bleeding, and the goal is to find the cause early.

If my Pap test was normal, can I still have endometrial cancer?

Yes. A normal Pap test does not rule out endometrial cancer because Pap tests are not designed to screen for it.

Bottom line

Endometrial (uterine) cancer is often detectable because it frequently causes symptomsespecially abnormal bleeding. Risk is influenced by hormones, age, metabolic health, certain medications, and genetics. Diagnosis typically hinges on an endometrial biopsy, and treatment commonly includes surgery, with radiation, chemotherapy, hormone therapy, or newer targeted/immunotherapy options used when appropriate.

If you remember only one thing, make it this: unexpected bleedingespecially after menopausedeserves medical attention. Not because you should panic, but because your future self will appreciate the clarity.

Experiences: what people often share (a 500-word, reality-based look)

Note: The following are composite experiences drawn from common themes patients and clinicians describe. They are not personal medical advice, and everyone’s journey is different.

1) “It was just a little spotting… until it wasn’t.”

One of the most repeated stories starts with a small surprise: a few spots of blood months or years after menopause. Many people assume it’s nothing (or blame stress, exercise, or “my body being weird”). Others wait because they don’t want to be dramatic. Then a second episode happensmaybe slightly heavier, maybe paired with mild pelvic pressureand the internal debate begins: Do I really need to call? When people do get checked, they often describe relief at simply having a plan. Even when the cause turns out to be benign, patients frequently say they wish they had called sooner, just to get out of the uncertainty spiral.

2) “I thought heavy periods were just my new normal.”

For premenopausal people, the pattern can look different: periods that gradually become heavier, cycles that start to drift, spotting between periods, or bleeding that seems to ignore the calendar completely. It’s easy to normalize changesespecially in your 40s, when perimenopause can cause chaos. People often say the “aha” moment was noticing a big shift from their baseline: needing to change products much more often, bleeding that lasted far longer than usual, or fatigue that didn’t match their lifestyle. Many describe feeling validated when a clinician took their symptoms seriously and explained that abnormal bleeding isn’t a moral failing or a “just deal with it” issueit’s a medical symptom worth evaluating.

3) “The word ‘biopsy’ freaked me out more than the appointment.”

Diagnostic testing can be emotionally intense. Patients often report that the waiting is the hardest part: waiting for the biopsy, waiting for results, waiting to find out what the next step is. A common coping trick people share is creating a “two-list system”: (1) questions for the clinician (What are we ruling out? What’s the timeline? What symptoms should trigger urgent care?), and (2) grounding activities for the in-between time (walks, a favorite show, meal prep, texting a friend). Patients also mention that bringing someone to appointmentsor even having them on speakerphonehelps them remember details and feel less alone.

4) “After treatment, I didn’t just want survival. I wanted my life back.”

When treatment includes surgery (like hysterectomy), people often talk about recovery in layers: the physical healing, the hormonal changes if ovaries are removed, and the emotional whiplash of “I’m okay… but I’m not the same.” Many find support groups or counseling surprisingly practicalless about inspirational speeches and more about real tips: managing fatigue, talking with partners, navigating follow-up visits, and dealing with fear of recurrence. A theme that shows up again and again is empowerment through information: understanding the diagnosis, knowing the follow-up plan, and learning what symptoms to report can turn anxiety into action. People don’t become robots about itthey just become less alone and more prepared.

If you or someone you care about is facing symptoms or a diagnosis, it’s okay to be nervous. It’s also okay to ask blunt questions, request clear explanations, and advocate for timely evaluation. Your body isn’t being “dramatic.” It’s being informative.